Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	3.79	2.45	5.96	7.85
Short-Term Investments	8.39	23	-	-	-
Cash & Short-Term Investments	8.39	26.79	2.45	5.96	7.85
Cash Growth	-68.67%	991.47%	-58.85%	-24.06%	562.47%
Accounts Receivable	1.52	0.6	-	-	-
Other Receivables	1.79	0.27	2.05	1.37	0.53
Total Trade Receivables	3.32	0.87	2.05	1.37	0.53
Other Current Assets	0.2	2.04	0.23	0.34	0.61
Total Current Assets	11.91	29.71	4.74	7.68	8.99
Net Property, Plant & Equipment	0.38	0.06	0.11	0.17	0.28
Other Intangible Assets	2.06	6.69	8.81	10.74	10.77
Other Long-Term Assets	0.06	0.03	0.05	0.08	0.09
Total Assets	24.25	36.48	13.71	18.68	20.13
Accounts Payable	-	0.42	0.21	1.01	0.16
Accrued Expenses	-	4.59	1.38	1.84	1.33
Current Portion of Leases	0.16	0.02	0.05	0.11	0.12
Other Current Liabilities	-	0.98	-	0.32	-
Total Current Liabilities	0.16	6.01	1.63	3.27	1.61
Long-Term Leases	0.2	0.03	0.06	-	0.09
Other Long-Term Liabilities	4.29	4.68	5.91	4	3.85
Total Long-Term Liabilities	4.5	4.72	5.97	4	3.94
Total Liabilities	8.13	10.72	7.6	7.27	5.55
Preferred Stock	0	0	-	-	-
Common Stock	0.28	0.27	0.08	0.02	0
Additional Paid-in Capital	170.31	169.16	153.19	146.04	135.54
Accumulated Other Comprehensive Income	-0.25	-0.28	-0.18	-0.18	-0.09
Retained Earnings	-154.22	-143.38	-146.98	-134.46	-120.88
Shareholders' Equity	16.13	25.76	6.11	11.41	14.58
Total Liabilities & Equity	24.25	36.48	13.71	18.68	20.13
Total Debt	0.37	0.06	0.11	0.11	0.21
Net Cash (Debt)	8.02	26.73	2.35	5.86	7.65
Net Cash Growth	-69.99%	1038.72%	-59.93%	-23.37%	1150.70%
Net Cash Per Share	1.96	6.48	4.36	72.00	285.39
Book Value	16.13	25.76	6.11	11.41	14.58
Book Value Per Share	3.93	6.24	11.36	140.20	544.22
Tangible Book Value	14.06	19.07	-2.7	0.66	3.81
Tangible Book Value Per Share	3.43	4.62	-5.03	8.17	142.26

Updated Mar 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q